Novo says twice as many Medicare patients prefer GLP-1 pill

Statele Unite

Novo Nordisk said its market research shows twice as many US Medicare recipients would rather take a weight-loss pill over a shot, says Executive Vice President of US Operations Jamey Millar

Novo says twice as many Medicare patients prefer GLP-1 pill Bloomberg Markets and Finance - 24.06.2026 22:50
Novo says twice as many Medicare patients prefer GLP-1 pill Bloomberg Markets and Finance - 24.06.2026 22:50

din zilele anterioare

Novo says twice as many Medicare patients prefer GLP-1 pill Bloomberg Markets and Finance - 24.06.2026 22:50
Novo says twice as many Medicare patients prefer GLP-1 pill Bloomberg Markets and Finance - 24.06.2026 22:50